| Literature DB >> 33410776 |
Ana Valenta Šobot1, Dunja Drakulić1, Gordana Joksić1, Jadranka Miletić Vukajlović1, Jasmina Savić1, Jelena Potočnik1, Jelena Filipović Tričković1.
Abstract
Yellow gentian (Gentiana lutea L.), a medicinal plant widely used in traditional medicine, displays multiple biological effects, ranging from beneficial to toxic. Since many promising applications have been reported so far, our aim was to evaluate its potential concentration- and time- dependent cytotoxic and genotoxic effects in vitro. To that end we exposed human peripheral blood mononuclear cells to 0.5, 1, and 2 mg/mL of yellow gentian root extract (YGRE) to determine its effects on oxidative stress parameters [pro/antioxidant balance (PAB) and lipid peroxidation], DNA damage (alkaline comet assay and chromosome aberrations), and cell viability (trypan blue exclusion test). Cell viability decreased with increasing concentrations and treatment duration. Only the lowest YGRE concentration (0.5 mg/mL) increased oxidative stress but produced minor DNA damage and cytotoxicity. At higher concentrations, redox parameters returned to near control values. The percentage of chromosome aberrations and percentage of DNA in the comet tail increased with increased YGRE concentration after 48 h and declined after 72 h of treatment. This points to the activation of DNA repair mechanism (homologous recombination), evidenced by the formation of chromosomal radial figures after 72 h of treatment with the highest YGRE concentration of 2 mg/mL. Our results suggest that YGRE, despite induction of cytotoxic and genotoxic effects, activates cell repair mechanisms that counter oxidative and DNA lesions and induce cell death in highly damaged cells. Therefore, observed protective effects of yellow gentian after longer exposure could be a result of activated repair and removal of cells with irreparable damage.Entities:
Keywords: Gentiana lutea L.; cytotoxicity; genotoxicity; homologous recombination; redox parameters
Mesh:
Substances:
Year: 2020 PMID: 33410776 PMCID: PMC7968512 DOI: 10.2478/aiht-2020-71-3476
Source DB: PubMed Journal: Arh Hig Rada Toksikol ISSN: 0004-1254 Impact factor: 2.078
Figure 1Particle size distribution of dispersed particles in (a) yellow gentian root powder; (b) lyophilisate; and (c) dissolved lyophilisate (pre-filtrate). Scale bar – 100 μm
Gradient condition details used for UPLC separation.
| time (min) | % B |
|---|---|
| 0 → 2 | 10 → 28 |
| 2 → 3.5 | 28 → 30 |
| 3.5 → 5 | 30 → 55 |
| 5 → 5.1 | 55 → 10 |
| 5.1 → 6 | 10 → |
Figure 2UPLC chromatograms of yellow gentian root extract in ethanol solution exported at 254 nm (a); 300 nm (b); 270 nm (c); and 240 nm (d). 1 – loganic acid; 2 – swertiamarin; 3 – overlapping gentiopicroside and sweroside peaks
Figure 3Cell viability expressed as percentage of control (a) and percentage of chromosome breaks (b) at different concentrations of yellow gentian root extract after 48 and 72 h treatment. *p<0.05, **p<0.01, ***p<0.001
Figure 4Photomicrograph of metaphase spreads after 72 h treatment with 2 mg/mL of yellow gentian root extract. Arrows mark chromatid break (a) and radial figure between two homologous chromosomes (17q) an indicator of homologous recombination - a mechanism of template-dependent DNA DSBs repair (b)
Figure 5Graph (a) and photomicrograph (b-e) of YGRE-induced DNA damage established with the comet assay. b – control; c – 0.5 mg/mL; d – 1 mg/mL; e – 2 mg/mL; YGRE – yellow gentian root extract. Scale bar – 10 μm. ***p<0.001
Figure 6PAB levels presented as arbitrary HK units (a) and LPP levels expressed as nmol/mg of proteins (b) after treatment with increasing concentrations of yellow gentian root extract. ***p<0.001